ATAI vs JCI · rev $4.1M vs P/E 44, rev $23.60B
ATAI Life Sciences BV (ATAI) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
ATAI currently screens at market cap $555.8M. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the ATAI and JCI stock pages for the full models.
Not investment advice.